New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
11:09 EDTCBS, VJET, CTRX, HZNP, YOKUOptions with increasing implied volatility: HZNP VJET YOKU CTRX CBS
News For HZNP;VJET;YOKU;CTRX;CBS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
November 23, 2015
10:41 EDTHZNPOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTHZNPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Adesto Technologies (IOTS) initiated with a Buy at Roth Capital... American Farmland (AFCO) initiated with an Outperform at Oppenheimer... Blackstone (BX) initiated with a Neutral at JPMorgan... California Resources (CRC) initiated with a Buy at Ladenburg... Calumet Specialty Products (CLMT) initiated with a Neutral at Goldman... Clearfield (CLFD) initiated with a Buy at Lake Street... Coherus Biosciences (CHRS) initiated with an Overweight at Barclays... Copa Holdings (CPA) initiated with a Buy at HSBC... GOL Linhas (GOL) initiated with a Reduce at HSBC... HP Enterprise (HPE) initiated with a Hold at Maxim... Himax (HIMX) initiated with an Overweight at Morgan Stanley... Horizon Pharma (HZNP) reinstated with a Buy at Jefferies... Match Group (MTCH) initiated with a Buy at Axiom... Mirati Therapeutics (MRTX) initiated with a Neutral at Citi... Momenta (MNTA) initiated with an Equal Weight at Barclays... MyoKardia (MYOK) initiated with an Outperform at Cowen... Revance (RVNC) initiated with a Buy at Guggenheim.
07:37 EDTHZNPHorizon Pharma reinstated with a Buy at Jefferies
Jefferies analyst David Steinberg reinstated Horizon Pharma (HZNP) with a Buy rating and reduced price target of $32. The company's standalone growth "appears healthy" and a near-term deal is likely following its failed attempt to acquire Depomed (DEPO), Steinberg tells investors in a research note.
06:12 EDTHZNPValeant questions spread to similar drug companies, WSJ says
Subscribe for More Information
November 22, 2015
13:11 EDTHZNPExpress Scripts' link to specialty drug makers presents new risk, Barron's says
Express Scripts' (ESRX) United BioSource unit -- often hired by specialty drug makers to help patients find money for costly treatments -- appears at odds with the company's role in negotiating lower drug prices, Barron's contends in a feature article. Though Express Scripts will continue to earn the "vast majority" of its profits as a pharmacy-benefit manager, Barron's argues that investors should view its work on behalf of specialty drug companies as a risk factor for the stock, particularly in light of recent Valeant (VRX) and Horizon (HZNP) headlines. Reference Link
November 20, 2015
10:03 EDTHZNPHorizon Pharma upgraded to Buy from Hold at Brean Capital
09:10 EDTHZNPOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Abercrombie & Fitch (ANF), up 16.3%... Foot Locker (FL), up 4.8%. ALSO HIGHER: Horizon Pharma (HZNP), up 1.6% after withdrawing offer to acquire Depomed (DEPO)... Nike (NKE), up 4.3% after announcing a $12B repurchase program, a two-for-one stock split, and that it will raise its dividend. DOWN AFTER EARNINGS: Nimble Storage (NMBL), down 45.3%... Mentor Graphics (MENT), down 28%. ALSO LOWER: Depomed, down 5.9% after Horizon Pharma withdrew its offer to acquire the company... Builders FirstSource (BLDR), down 3.7% after 7M share Spot Secondary priced at $13.25.
05:17 EDTHZNPDepomed comments on Horizon Pharma withdrawal of offer to acquire company
Subscribe for More Information
05:13 EDTHZNPHorizon Pharma withdraws offer to acquire Depomed
Horizon Pharma (HZNP) announced that at a hearing, Judge Peter Kirwan of the Superior Court of California for the County of Santa Clara granted Depomed's (DEPO) motion for preliminary injunctive relief against Horizon Pharma's alleged use of information that Depomed claimed was confidential. In his ruling, Judge Kirwan did not grant the injunctive relief Horizon Pharma had sought regarding the legality of Depomed's poison pill and certain of the bylaw amendments announced by Depomed's board of directors on July 13. While we strongly disagree with the court's ruling, we are withdrawing our offer to acquire Depomed," said Timothy P. Walbert, chairman, president and CEO, Horizon Pharma. "Today's ruling by the court does not affect our 2016 guidance or long-range plan or expectations. We have built a strong and diversified portfolio of medicines that we expect will exceed $750Mn in net sales in 2015 and we expect will drive nearly $1B in net sales in 2016. As we look to the future, we are committed to our strategy of complementing our strong organic growth, which has the potential to double our net sales to approximately $2B by 2020, with value enhancing acquisitions. While we are disappointed by the court's ruling, Depomed was only one of many attractive acquisition opportunities we have been actively pursuing."
November 19, 2015
19:05 EDTYOKUYouku Tudou reports Q3 non-GAAP EPS (RMB1.62), consensus (RMB1.58)
Subscribe for More Information
November 17, 2015
10:20 EDTHZNPOptions with increasing implied volatility
Options with increasing implied volatility: SGMS HZNP CSC ULTA RH BURL GME AEO BBRY TIF
November 16, 2015
10:43 EDTHZNPOptions with increasing implied volatility
Subscribe for More Information
November 13, 2015
14:06 EDTHZNPHorizon Pharma extends exchange offer to acquire Depomed
Subscribe for More Information
11:38 EDTCBSBox Office Battle: 'Spectre,' 'The Peanuts Movie' expected to remain on top
Sony's (SNE) "Spectre," starring Daniel Craig as James Bond, is again expected to top the box office in its second weekend at theaters, with an estimated domestic gross in the $30.3M-$32.4M range. Fox's (FOX, FOXA) G-rated family film "The Peanuts Movie," starring a 3D-animated Charlie Brown, is again likely to come in second, predicted to earn an additional $28.7M. Newcomer "The 33," a drama retelling the true story of the Chilean miners that were trapped underground in 2010, is expected to open between $5.5M-$10M in 2,400 theaters. "The 33" is being distributed in North America by Time Warner's (TWX) Warner Bros. Pictures, and in Latin America by Fox's 20th Century Fox. Holiday dramedy "Love the Coopers," starring John Goodman and Diane Keaton, is estimated to open in the $5.2M-$8M range. "Love the Coopers" is being released in 2,603 theaters by Lionsgate (LGF) and CBS's (CBS) CBS Films. Fox's "The Martian," which opened on October 2, is predicted to earn an additional $6M-$6.8M. Other publicly traded companies involved in filmmaking include Comcast (CMCSA, CMCSK), Disney (DIS), and Viacom (VIA, VIAB).
11:33 EDTCBSStocks with call strike movement; CBS CMG
Subscribe for More Information
10:53 EDTCBSCBS management to meet with Barrington
Subscribe for More Information
10:50 EDTHZNPOptions with increasing implied volatility
Subscribe for More Information
November 12, 2015
18:54 EDTVJETvoxeljet backs FY15 revenue guidance of EUR 23M-EUR 24M
18:54 EDTVJETvoxeljet reports Q3 EPS (EUR 0.91) vs. (EUR 0.41) last year
Subscribe for More Information
05:23 EDTHZNPStocks with implied volatility movement; HZNP ESRX
Stocks with implied volatility movement; Horizon Pharma (HZNP) 123, Express Scripts (ESRX) 32 according to iVolatility.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use